Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases [0.03%]
用于治疗退行性眼病的基底纳米纤维支架的组织工程视网膜色素上皮细胞疗法
Nathan A Hotaling,Vladimir Khristov,Qin Wan et al.
Nathan A Hotaling et al.
Clinical-grade manufacturing of a functional retinal pigment epithelium (RPE) monolayer requires reproducing, as closely as possible, the natural environment in which RPE grows. In vitro, this can be achieved by a tissue engineering approac...
Ankita Salvi,Pratik Bankhele,Jamal Jamil et al.
Ankita Salvi et al.
Purpose: In this study, we investigated the effect of a slow-releasing hydrogen sulfide (H2S) donor, GYY 4137, on intraocular pressure (IOP) in normotensive rabbits. Furthermore, we compared the IOP-lowering action of GYY...
Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment [0.03%]
雷珠单抗玻璃体内注射联合曲安奈德巩膜下注射治疗牵拉性糖尿病黄斑水肿伴视网膜脱离的疗效观察
Nimet Yesim Ercalik,Nursal Melda Yenerel,Serhat Imamoglu et al.
Nimet Yesim Ercalik et al.
Purpose: To evaluate the efficacy of intravitreal ranibizumab (IVR) combined with posterior sub-Tenon injection of triamcinolone acetonide (STTA) for treatment of diabetic macular edema (DME) with serous retinal detachmen...
Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill [0.03%]
量化青光眼药物的依从性：自报、电子监测和药房复查之间的关系
Jaya B Kumar,Hayden B Bosworth,Betsy Sleath et al.
Jaya B Kumar et al.
Purpose: Glaucoma medications reduce the risk of progressive visual field loss, but adherence to these medications is often poor. A better understanding of the appropriate metrics for quantifying glaucoma medication adher...
Response #1 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016 [0.03%]
右眼玻璃体内注射德宝松植入剂后的眼内压变化；Alagöz等人的研究报告
Osman Çekiç,Semra Akkaya Turhan
Osman Çekiç
A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers [0.03%]
一项在健康成人受试者中评估Trabodenoson随机序贯给药的安全性、耐受性和药代动力学的I期剂量递增研究
Alan Laties,Cadmus C Rich,Randall Stoltz et al.
Alan Laties et al.
Purpose: To investigate the safety, tolerability, and pharmacokinetics of trabodenoson, a highly selective adenosine mimetic targeting the adenosine A1 receptor. ...
Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement [0.03%]
视网膜退行性疾病的诱导多能干细胞疗法：疾病建模与细胞替代治疗
Valentina Di Foggia,Priyanka Makwana,Robin R Ali et al.
Valentina Di Foggia et al.
Stem cell therapies are being explored as potential treatments for retinal disease. How to replace neurons in a degenerated retina presents a continued challenge for the regenerative medicine field that, if achieved, could restore sight. Th...
Accelerated (18 mW/cm(2)) Corneal Cross-Linking for Progressive Keratoconus: 18-Month Results [0.03%]
加速（18毫瓦/平方厘米）角膜交联疗法治疗进行性角膜扩张病的18个月结果研究报告
Tugba Kurt,Engin Bilge Ozgurhan,Yusuf Yildirim et al.
Tugba Kurt et al.
Purpose: The aim of this study is to report the results of 18 months of follow-up after treatment with accelerated (18 mW/cm(2)) corneal cross-linking in patients with progressive keratoconus. ...